GB2406517A — Controlled release micropellets of tetracyclines
Assigned to Accord UK Ltd · Expires 2005-04-06 · 21y expired
What this patent protects
The present invention concerns a controlled release dosage form comprising (I) a tetracycline, (II) an excipient selected from waxes, fats or glycerides or other esters of fatty acids with polyols and (III) a cellulose or acrylate polymer or polyvinyl - pyrrolidone; (II) is prese…
USPTO Abstract
The present invention concerns a controlled release dosage form comprising (I) a tetracycline, (II) an excipient selected from waxes, fats or glycerides or other esters of fatty acids with polyols and (III) a cellulose or acrylate polymer or polyvinyl - pyrrolidone; (II) is present in a range of 8.35% of (I) and (III) is present in the range of 20 - 100% of (I). Preferred is a capsule containing pellets of minocycline, glycerol monostearate, cellulose and polyvinyl pyrrolidone.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.